Dissecting and fine-mapping trans-eQTL hotspotskbroman/presentations/ncsu2017.pdf · Dissecting and...

39
Dissecting and fine-mapping trans-eQTL hotspots Karl Broman Biostatistics & Medical Informatics University of Wisconsin–Madison, USA kbroman.org github.com/kbroman @kwbroman Slides: bit.ly/ncsu2017

Transcript of Dissecting and fine-mapping trans-eQTL hotspotskbroman/presentations/ncsu2017.pdf · Dissecting and...

Dissecting and fine-mappingtrans-eQTL hotspots

Karl Broman

Biostatistics & Medical InformaticsUniversity of WisconsinMadison, USA

kbroman.orggithub.com/kbroman@kwbromanSlides: bit.ly/ncsu2017

http://kbroman.orghttps://github.com/kbromanhttps://twitter.com/kwbromanhttp://bit.ly/ncsu2017

2

daviddeen.com

3

http://daviddeen.com

Intercross

P1 P2

F1 F1

F2

4

QTL mapping

0

2

4

6

8

Chromosome

LOD

sco

re

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 X

5

QTL mapping

0

2

4

6

8

Chromosome

LOD

sco

re

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 X

BB BR RR

0.8

0.9

1.0

1.1

5

6

B6 BTBR, Lepob/obislet

QTL position (cM)

Pro

be p

ositi

on (

cM)

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 X

1

2

3

4

5

6

7

8

9

10

11

12

13

14

1516171819

X

7

B6 BTBR, Lepob/obislet

QTL position (cM)

Pro

be p

ositi

on (

cM)

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 X

1

2

3

4

5

6

7

8

9

10

11

12

13

14

1516171819

X

adipose

QTL position (cM)P

robe

pos

ition

(cM

)1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 X

1

2

3

4

5

6

7

8

9

10

11

12

13

14

1516171819

X

gastroc

QTL position (cM)

Pro

be p

ositi

on (

cM)

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 X

1

2

3

4

5

6

7

8

9

10

11

12

13

14

1516171819

X

hypo

QTL position (cM)

Pro

be p

ositi

on (

cM)

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 X

1

2

3

4

5

6

7

8

9

10

11

12

13

14

1516171819

X

kidney

QTL position (cM)

Pro

be p

ositi

on (

cM)

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 X

1

2

3

4

5

6

7

8

9

10

11

12

13

14

1516171819

X

liver

QTL position (cM)

Pro

be p

ositi

on (

cM)

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 X

1

2

3

4

5

6

7

8

9

10

11

12

13

14

1516171819

X

8

Chr 6islet

LOD

sco

re

0 20 40 60 80 1000

25

50

75

100

125

150

175

Position (cM)

adipose

LOD

sco

re0 20 40 60 80 100

0

25

50

75

100

125

150

175

Position (cM)

gastroc

LOD

sco

re

0 20 40 60 80 1000

25

50

75

100

125

150

175

Position (cM)

hypo

LOD

sco

re

0 20 40 60 80 1000

25

50

75

100

125

150

175

Position (cM)

kidney

LOD

sco

re

0 20 40 60 80 1000

25

50

75

100

125

150

175

Position (cM)

liver

LOD

sco

re0 20 40 60 80 100

0

25

50

75

100

125

150

175

Position (cM)

9

Consider the non-recombinants

QTL

10

Consider the non-recombinants

QTL

10

Islet c6 PCs

Principal component 1

Prin

cipa

l com

pone

nt 2

3 2 1 0 1 2 3

0.8

0.6

0.4

0.2

0.0

0.2

0.4

0.6

0.8

1.0

BB

BR

RR

11

Islet c6 PCs

Principal component 1

Prin

cipa

l com

pone

nt 2

3 2 1 0 1 2 3

0.8

0.6

0.4

0.2

0.0

0.2

0.4

0.6

0.8

1.0

BB

BR

RR

recombinant

11

Fine-mapping the c6 locus

Mouse

Pos

ition

(M

bp)

145.73144.91

141.52

135.27

QTL

BB BR RR

12

Fine-mapping the c6 locus

Mouse

Pos

ition

(M

bp)

145.73144.91

141.52

135.27

QTL

BB BR RR

Mouse

Pos

ition

(M

bp)

145.24

142.42

141.52

139.94

QTL

12

Fine-mapping the c6 locus

Mouse

Pos

ition

(M

bp)

145.73144.91

141.52

135.27

QTL

BB BR RR

Mouse

Pos

ition

(M

bp)

145.24

142.42

141.52

139.94

QTL

Mouse

Pos

ition

(M

bp)

142.42

142.28

141.97

141.52

QTL

Slco1a6

Slco1a5Iapp

12

Is it one QTL?

13

Consider the QTL effects

BB BR RR

d

a

14

eQTL effects: Islet c6

signed LOD

QTL pos (cM)

200

150

100

50

0

50

100

150

200

75 80 85 90 95 100 105

sign

ed L

OD

sco

re

0.5 0.0 0.5

0.5

0.0

0.5

Inheritance Pattern

Additive effect

Dom

inan

ce e

ffect

15

eQTL effects: Kidney c13

signed LOD

QTL pos (cM)

60

50

40

30

20

10

0

10

20

30

40

50

60

45 50 55 60 65 70 75

sign

ed L

OD

sco

re

0.2 0.1 0.0 0.1 0.2

0.2

0.1

0.0

0.1

0.2

Inheritance Pattern

Additive effect

Dom

inan

ce e

ffect

16

eQTL effects: Islet c2

signed LOD

QTL pos (cM)

150

100

50

0

50

100

150

45 55 65 75 85 95

sign

ed L

OD

sco

re

0.2 0.1 0.0 0.1 0.2

0.2

0.1

0.0

0.1

0.2

Inheritance Pattern

Additive effect

Dom

inan

ce e

ffect

17

eQTL effects: Liver c17

signed LOD

QTL pos (cM)

150

100

50

0

50

100

150

6 8 10 14 18 22 26

sign

ed L

OD

sco

re

0.4 0.2 0.0 0.2 0.4

0.4

0.2

0.0

0.2

0.4

Inheritance Pattern

Additive effect

Dom

inan

ce e

ffect

18

eQTL effects: Adipose c10

signed LOD

QTL pos (cM)

200

150

100

50

0

50

100

150

200

38 42 46 50 54 58

sign

ed L

OD

sco

re

0.4 0.2 0.0 0.2 0.4

0.4

0.2

0.0

0.2

0.4

Inheritance Pattern

Additive effect

Dom

inan

ce e

ffect

19

Compare the recombinantsand non-recombinants.

20

LDA & PCA: Islet c6

Linear Discriminant 1

Line

ar D

iscr

imin

ant 2

15 10 5 0 5 10 15

4

2

0

2

LDA

Principal Component 1

Prin

cipa

l Com

pone

nt 2

3 2 1 0 1 2 3

1.0

0.5

0.0

0.5

1.0

PCA

BB BR RR Recombinant

21

LDA & PCA: Islet c2

Linear Discriminant 1

Line

ar D

iscr

imin

ant 2

10 5 0 5 10

2

0

2

4

6

LDA

Principal Component 1

Prin

cipa

l Com

pone

nt 2

1.5 1.0 0.5 0.0 0.5 1.0 1.5

0.5

0.0

0.5

PCA

BB BR RR Recombinant

22

LDA & PCA: Kidney c13

Linear Discriminant 1

Line

ar D

iscr

imin

ant 2

6 4 2 0 2 4

2

0

2

4

LDA

Principal Component 1

Prin

cipa

l Com

pone

nt 2

3 2 1 0 1 21.0

0.5

0.0

0.5

1.0

PCA

BB BR RR Recombinant

23

LDA & PCA: Liver c17

Linear Discriminant 1

Line

ar D

iscr

imin

ant 2

5 0 5 10

2

0

2

4

LDA

Principal Component 1

Prin

cipa

l Com

pone

nt 2

2 1 0 1 2

1.5

1.0

0.5

0.0

0.5

1.0

PCA

BB BR RR Recombinant

24

LDA & PCA: Adipose c10

Linear Discriminant 1

Line

ar D

iscr

imin

ant 2

5 0 5 1010

5

0

5

LDA

Principal Component 1

Prin

cipa

l Com

pone

nt 2

1 0 1 2 3

1.0

0.5

0.0

0.5

1.0

PCA

BB BR RR Recombinant

25

Formal test for 1 vs 2 QTL

Consider a set of traits mapping to common eQTL

Multivariate QTL analysis with 1 or 2 QTL

With 2-QTL model, each trait affected by one or theother QTL

Order traits by estimated QTL location when consideredseparately

Consider cut points of the list, assign first group to oneQTL and second group to other.

P-value: parametric bootstrap or stratifiedpermutation

26

1 vs 2 QTL: Kidney c13

LOD profile

Map position (cM)

LOD

sco

re

50 55 60 650

50

100

150

200

LOD diff by cutpoint

cut point

LOD

diff

10 20 30 400

10

20

30

27

1 vs 2 QTL: Islet c6

LOD profile

Map position (cM)

LOD

sco

re

80 85 90 950

100

200

300

LOD diff by cutpoint

cut point

LOD

diff

10 20 30 400.0

0.5

1.0

1.5

2.0

28

1 vs 2 QTL: Islet c2

LOD profile

Map position (cM)

LOD

sco

re

50 60 70 80 900

100

200

300

400

LOD diff by cutpoint

cut point

LOD

diff

10 20 30 400

20

40

60

80

29

1 vs 2 QTL: Liver c17

LOD profile

Map position (cM)

LOD

sco

re

5 10 15 20 250

50

100

150

200

250

LOD diff by cutpoint

cut point

LOD

diff

10 20 30 400

5

10

15

20

25

30

1 vs 2 QTL: Adipose c10

LOD profile

Map position (cM)

LOD

sco

re

40 45 50 550

100

200

300

400

500

LOD diff by cutpoint

cut point

LOD

diff

10 20 30 400

20

40

60

80

100

31

Summary Fine-mapping a trans-eQTL hotspot

Consider the non-recombinants Predict QTL genotype of recombinants

Mendelian trait Fine-map by traditional means

Large-effect locus on chr 6 Affects expression of 8% of genes Effects specific to pancreatic islets Looks to be Slco1a6

Dissecting a trans-eQTL hotspot Sign of eQTL effect Degree of dominance Compare recombinants and non-recombinants Formal statistical test

32

AcknowledgmentsUniv. WisconsinMadison

Jianan Tian Brian YandellAlan Attie Angie OlerMark Keller Mary RabagaliaAimee Teo Broman Kathryn SchuelerChristina Kendziorski Donald Stapleton

Univ. Kansas Medical CenterBruno Hagenbuch Wen Zhao

Merck & Co., Inc.Amit Kulkarni

Mt. SinaiEric Schadt

NIH: R01 GM074244, R01 DK066369

33

Slides: bit.ly/ncsu2017

kbroman.orggithub.com/kbroman@kwbroman

Tian J et al. (2015) Identification of the bile acid transporter Slco1a6as a candidate gene that broadly affects gene expression in mousepancreatic islets. Genetics 201:12531262

Tian J et al. (2016) The dissection of expression quantitative traitlocus hotspots. Genetics 202:15631574

34

http://bit.ly/ncsu2017http://kbroman.orghttps://github.com/kbromanhttps://twitter.com/kwbromanhttps://www.biostat.wisc.edu/~kbroman/publications/islet_chr6.pdfhttps://www.biostat.wisc.edu/~kbroman/publications/islet_chr6.pdfhttps://www.biostat.wisc.edu/~kbroman/publications/islet_chr6.pdfhttps://www.biostat.wisc.edu/~kbroman/publications/transbandpaper_wsupp.pdfhttps://www.biostat.wisc.edu/~kbroman/publications/transbandpaper_wsupp.pdf